Cargando…

The value of adjuvant chemotherapy in stage II/III colorectal signet ring cell carcinoma

This study aimed to assess the benefit of postoperative adjuvant chemotherapy in stage II–III colorectal signet ring cell carcinoma (SRCC). Qualified postoperative patients were extracted from Surveillance, Epidemiology, and End Results (SEER) database from 2004 until 2015. We collected 1675 patient...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhao, Zhuang, Yan, Na, Pan, Shu, Wang, Dun-wei, Li, Zhi-wen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7445263/ https://www.ncbi.nlm.nih.gov/pubmed/32839528 http://dx.doi.org/10.1038/s41598-020-70985-0

Ejemplares similares

Improving survival of stage II‐III primary gastric signet ring cell carcinoma by adjuvant chemoradiotherapy
por: Li, Yang, et al.
Publicado: (2020)

The Predictive and Guidance Value of Signet Ring Cell Histology for Stage II/III Colon Cancer Response to Chemotherapy
por: Jiang, Huici, et al.
Publicado: (2021)

Superior survival in right-sided versus left-sided colon signet ring cell carcinoma
por: Zhao, Zhuang, et al.
Publicado: (2020)

Chemoradiotherapy Is Inferior to Chemotherapy Alone in Adjuvant Setting for Signet Ring Cell Containing Gastric Cancer
por: Zhu, Yue-Ting, et al.
Publicado: (2020)

Early Images of Colorectal Signet Ring Cell Carcinoma
por: Fujita, Kinya, et al.
Publicado: (2022)

Irregular delay of adjuvant chemotherapy correlated with poor outcome in stage II-III colorectal cancer
por: Chen, Yuanyuan, et al.
Publicado: (2022)

BRAF mutation in colorectal carcinomas with signet ring cell component
por: Yalcin, Serap, et al.
Publicado: (2017)

Prognosis and value of preoperative radiotherapy in locally advanced rectal signet-ring cell carcinoma
por: Ling, Chun-Run, et al.
Publicado: (2017)

Individualised adjuvant immunotherapy with neoantigen‐reactive T cells for gastric signet‐ring cell carcinoma
por: Ding, Naiqing, et al.
Publicado: (2023)

Primary vaginal signet ring cell carcinoma
por: Huang, Xiao-Shan, et al.
Publicado: (2022)

The prognostic significance of different proportion of signet-ring cells of colorectal carcinoma
por: Chen, Wei, et al.
Publicado: (2022)

Colorectal Signet Ring Cell Carcinoma Presenting as Ulcerating Rectosigmoid Stricture
por: Chen, Bing, et al.
Publicado: (2023)

Clinicopathological Characteristics and Prognostic Value of Signet Ring Cells in Gastric Carcinoma: A Meta-Analysis
por: Nie, Run-Cong, et al.
Publicado: (2017)

Signet Ring Cell Colorectal and Appendiceal Cancer: A Small Signet Ring Cell Component Is Also Associated with Poor Outcome
por: Enblad, Malin, et al.
Publicado: (2023)

Clinical predictive value of in vitro anticancer drug sensitivity test for the therapeutic effect of adjuvant chemotherapy in patients with stage II–III colorectal cancer
por: MEKATA, EIJI, et al.
Publicado: (2013)

Signet ring carcinoma of ampulla of vater
por: Talebi, Ardeshir, et al.
Publicado: (2014)

Effects of Tumor Localization, Age, and Stage on the Outcomes of Gastric and Colorectal Signet Ring Cell Adenocarcinomas
por: Benesch, Matthew G. K., et al.
Publicado: (2023)

Pathologic Factors Associated with Prognosis after Adjuvant Chemotherapy in Stage II/III Microsatellite-Unstable Colorectal Cancers
por: Kim, Jung Ho, et al.
Publicado: (2015)

Nutritional status predicts adjuvant chemotherapy outcomes for stage III colorectal cancer
por: Ihara, Keisuke, et al.
Publicado: (2019)

Prognosis of stage III colorectal carcinomas with FOLFOX adjuvant chemotherapy can be predicted by molecular subtype
por: Kwon, Yujin, et al.
Publicado: (2017)

Clinical Features and Prognosis of Resectable Primary Colorectal Signet-Ring Cell Carcinoma
por: Lee, Ho-Su, et al.
Publicado: (2015)

Signet ring colorectal carcinoma: Do we need to improve the treatment algorithm?
por: Tamhankar, Anup Sunil, et al.
Publicado: (2016)

Clinicopathological and Molecular Characteristics of Colorectal Signet Ring Cell Carcinoma: A Review
por: An, Yang, et al.
Publicado: (2021)

Adjuvant Chemotherapy Benefit in Elderly Stage II/III Colon Cancer Patients
por: Chen, Xin, et al.
Publicado: (2022)

Primary Gastric Signet Ring Cell Carcinoma or Metastatic Lobular Carcinoma With Signet Ring Cells: A Diagnostic Challenge
por: Akouh, Nada, et al.
Publicado: (2023)

Adjuvant Chemotherapy for Stage III Colon Cancer
por: Taieb, Julien, et al.
Publicado: (2020)

Long-Term Survival of a Patient with Invasive Signet-Ring Cell Carcinoma of the Urinary Bladder Managed by Combined S-1 and Cisplatin Adjuvant Chemotherapy
por: Hamakawa, Takashi, et al.
Publicado: (2013)

The enigma of signet ring cells
por: Sharma, Gitika, et al.
Publicado: (2020)

Change in clinical outcomes during the transition of adjuvant chemotherapy for stage III colorectal cancer
por: Osumi, Hiroki, et al.
Publicado: (2017)

The efficacy of oxaliplatin combination adjuvant chemotherapy for elderly patients with stage III colorectal cancer
por: Hayashi, Naomi, et al.
Publicado: (2020)

Association between diabetes and adjuvant chemotherapy implementation in patients with stage III colorectal cancer
por: Kanehara, Rieko, et al.
Publicado: (2022)

Secondary Signet Ring Cell Carcinoma of Prostate
por: Khan, Kalyan, et al.
Publicado: (2012)

Mucinous carcinoma of the gallbladder with signet ring cells
por: Fukuda, Takeshi, et al.
Publicado: (2017)

Signet-Ring Cell Morphotype in Lung Carcinoma
por: Handra-Luca, Adriana
Publicado: (2020)

A Case of Primary Signet-Ring Cell Cervical Carcinoma Treated with Chemoradiation, Brachytherapy, and Adjuvant Hysterectomy
por: Salmen, Nicole, et al.
Publicado: (2021)

GALNT14 Genotype Predicts Postoperative Outcome of Stage III Colorectal Cancer With Oxaliplatin as Adjuvant Chemotherapy
por: Lin, Wey-Ran, et al.
Publicado: (2016)

Gastric metastasis of mammary signet ring cell carcinoma--a differential diagnosis with primary gastric signet ring cell carcinoma.
por: Yim, H., et al.
Publicado: (1997)

Characteristics and prognostic factors of colorectal mucinous adenocarcinoma with signet ring cells
por: Kong, Xiangquan, et al.
Publicado: (2017)

Clinicopathologic and Molecular Features of Colorectal Adenocarcinoma with Signet-Ring Cell Component
por: Wei, Qing, et al.
Publicado: (2016)

Phase II/III multicentre randomised controlled trial evaluating a strategy of primary surgery and adjuvant chemotherapy versus peri-operative chemotherapy for resectable gastric signet ring cell adenocarcinomas – PRODIGE 19 – FFCD1103 – ADCI002
por: Piessen, Guillaume, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_ahrnbp7of6gqoat34dt9l4b78t